Skip to main content
Clinical Trials/NCT04603378
NCT04603378
Completed
N/A

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects Using a Stable Isotope

Kaleido Biosciences1 site in 1 country47 target enrollmentSeptember 18, 2017
ConditionsHealthy

Overview

Phase
N/A
Intervention
Not specified
Conditions
Healthy
Sponsor
Kaleido Biosciences
Enrollment
47
Locations
1
Primary Endpoint
Number of patients experiencing any treatment-emergent adverse events (TEAEs)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This exploratory, randomized, double-blind, placebo-controlled study aims to explore the effect of novel glycans on nitrogen metabolism in the gut in healthy subjects using a stable isotope.

Registry
clinicaltrials.gov
Start Date
September 18, 2017
End Date
November 28, 2017
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kaleido Biosciences
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of patients experiencing any treatment-emergent adverse events (TEAEs)

Time Frame: Day -8 to Day 29

Study Sites (1)

Loading locations...

Similar Trials